Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Aarti Drugs Ltd.
NSE: AARTIDRUGS
|
BSE: 524348
|
ISIN: INE767A01016
|
Industry: Pharmaceuticals
MD Appointment
|
Mid-range Performer
407.2500
-15.50
(
-3.67
%)
NSE
Aug 03, 2026
15:31 PM
27.68% Gain from 52W Low
Volume:
383.2K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Aarti Drugs Ltd.
30 Jul 2024
MD Appointment
407.25
-3.67%
Result Update:Aarti Drugs
Buy:
Aarti Drugs Ltd.
by
Axis Direct
Target: 555
Target
Axis Direct
We have BUY on the stock
Aarti Drugs Ltd. has an
average target
of 480.00 from 1 broker.
More from Aarti Drugs Ltd.
Recommended
IPO market buzzes as KKR-backed LEAP India lines up Rs 2,480 crore issue
|
03 Aug 2026, 06:15PM
Market closes higher as oil prices fall amid easing geopolitical concerns
Trendlyne Marketwatch |
03 Aug 2026, 03:58PM
Earnings Call Transcript - Q1FY21 for Aarti Drugs
|
27 Jul 2020